225 related articles for article (PubMed ID: 29800827)
1. Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P
Nguyen W; Hodder AN; de Lezongard RB; Czabotar PE; Jarman KE; O'Neill MT; Thompson JK; Jousset Sabroux H; Cowman AF; Boddey JA; Sleebs BE
Eur J Med Chem; 2018 Jun; 154():182-198. PubMed ID: 29800827
[TBL] [Abstract][Full Text] [Related]
2. Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity.
Richardson LW; Ashton TD; Dans MG; Nguyen N; Favuzza P; Triglia T; Hodder AN; Ngo A; Jarman KE; Cowman AF; Sleebs BE
ChemMedChem; 2022 Sep; 17(18):e202200306. PubMed ID: 35906744
[TBL] [Abstract][Full Text] [Related]
3. Transition state mimetics of the Plasmodium export element are potent inhibitors of Plasmepsin V from P. falciparum and P. vivax.
Sleebs BE; Gazdik M; O'Neill MT; Rajasekaran P; Lopaticki S; Lackovic K; Lowes K; Smith BJ; Cowman AF; Boddey JA
J Med Chem; 2014 Sep; 57(18):7644-62. PubMed ID: 25167370
[TBL] [Abstract][Full Text] [Related]
4. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
[TBL] [Abstract][Full Text] [Related]
5. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
[TBL] [Abstract][Full Text] [Related]
6. Azole-based non-peptidomimetic plasmepsin inhibitors.
Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the P3 region of PEXEL peptidomimetics leads to a potent inhibitor of the Plasmodium protease, plasmepsin V.
Gazdik M; Jarman KE; O'Neill MT; Hodder AN; Lowes KN; Jousset Sabroux H; Cowman AF; Boddey JA; Sleebs BE
Bioorg Med Chem; 2016 May; 24(9):1993-2010. PubMed ID: 27021426
[TBL] [Abstract][Full Text] [Related]
8. Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present).
Cheuka PM; Dziwornu G; Okombo J; Chibale K
J Med Chem; 2020 May; 63(9):4445-4467. PubMed ID: 31913032
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in silico studies of naphthoquinones and peptidomimetics toward Plasmodium falciparum plasmepsin V.
Sittikul P; Songtawee N; Kongkathip N; Boonyalai N
Biochimie; 2018 Sep; 152():159-173. PubMed ID: 30103899
[TBL] [Abstract][Full Text] [Related]
10. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
Dali B; Keita M; Megnassan E; Frecer V; Miertus S
Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033
[TBL] [Abstract][Full Text] [Related]
11. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.
Carroll CD; Patel H; Johnson TO; Guo T; Orlowski M; He ZM; Cavallaro CL; Guo J; Oksman A; Gluzman IY; Connelly J; Chelsky D; Goldberg DE; Dolle RE
Bioorg Med Chem Lett; 1998 Sep; 8(17):2315-20. PubMed ID: 9873534
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.
Hodder AN; Sleebs BE; Czabotar PE; Gazdik M; Xu Y; O'Neill MT; Lopaticki S; Nebl T; Triglia T; Smith BJ; Lowes K; Boddey JA; Cowman AF
Nat Struct Mol Biol; 2015 Aug; 22(8):590-6. PubMed ID: 26214367
[TBL] [Abstract][Full Text] [Related]
13. Role of plasmepsin V in export of diverse protein families from the Plasmodium falciparum exportome.
Boddey JA; Carvalho TG; Hodder AN; Sargeant TJ; Sleebs BE; Marapana D; Lopaticki S; Nebl T; Cowman AF
Traffic; 2013 May; 14(5):532-50. PubMed ID: 23387285
[TBL] [Abstract][Full Text] [Related]
14. Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'.
Romeo S; Dell'Agli M; Parapini S; Rizzi L; Galli G; Mondani M; Sparatore A; Taramelli D; Bosisio E
Bioorg Med Chem Lett; 2004 Jun; 14(11):2931-4. PubMed ID: 15125962
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.
Mishra V; Rathore I; Arekar A; Sthanam LK; Xiao H; Kiso Y; Sen S; Patankar S; Gustchina A; Hidaka K; Wlodawer A; Yada RY; Bhaumik P
FEBS J; 2018 Aug; 285(16):3077-3096. PubMed ID: 29943906
[TBL] [Abstract][Full Text] [Related]
16. PEXEL is a proteolytic maturation site for both exported and non-exported
Fierro MA; Muheljic A; Sha J; Wohlschlegel J; Beck JR
mSphere; 2024 Feb; 9(2):e0039323. PubMed ID: 38334391
[TBL] [Abstract][Full Text] [Related]
17. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
Zürcher M; Gottschalk T; Meyer S; Bur D; Diederich F
ChemMedChem; 2008 Feb; 3(2):237-40. PubMed ID: 17918177
[No Abstract] [Full Text] [Related]
18. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Hidaka K; Kimura T; Ruben AJ; Uemura T; Kamiya M; Kiso A; Okamoto T; Tsuchiya Y; Hayashi Y; Freire E; Kiso Y
Bioorg Med Chem; 2008 Dec; 16(23):10049-60. PubMed ID: 18952439
[TBL] [Abstract][Full Text] [Related]
19. New potent C2-symmetric malaria plasmepsin I and II inhibitors.
Oscarsson K; Oscarson S; Vrang L; Hamelink E; Hallberg A; Samuelsson B
Bioorg Med Chem; 2003 Apr; 11(7):1235-46. PubMed ID: 12628651
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
Nezami A; Luque I; Kimura T; Kiso Y; Freire E
Biochemistry; 2002 Feb; 41(7):2273-80. PubMed ID: 11841219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]